These strategies assist in reducing BMI, improving insulin sensitivity, and decreasing inflammatory markers, leading to a general improvement of metabolic health and possibly preventing obesity-related comorbidities. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.